Ignite Creation Date:
2024-05-05 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004104
Status:
COMPLETED
Last Update Posted:
2016-03-31
First Post:
1999-12-10
Brief Title:
Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma
Sponsor:
Organization:
NYU Langone Health